Overview

BAY38-9456 - Supportive Trial for Spinal Injury

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
BAY 38-9456 10 mg and 20 mg can be given as safe and efficacious medications to patients with spinal cord injury suffering from erectile dysfunction, and that erectile dysfunction can be improved by uptitration to BAY 38-9456 20 mg when the treatment with 10 mg is not sufficiently effective
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Vardenafil Dihydrochloride